Cancer studies sometimes focus on learning new ways to treat or manage the condition. Medical studies sometimes examine existing drugs to check whether they can be useful for other medical conditions. One drug that has attracted significant attention in medical research is Ivermectin. There is a lot of speculation about whether ivermectin and cancer treatment have a connection.
Ivermectin is a drug commonly used to treat and manage parasites in humans. The drug has also been tested in a laboratory setting to check its potential impact on cancer cells. While some studies have shown some interesting results, let’s examine what science really says.
What Is Ivermectin?
Ivermectin is a medicine used to treat parasitic infections. Doctors prescribe it for the treatment of diseases like Strongyloidiasis and Onchocerciasis. These are parasitic infections that occur when a parasite or a worm infects the body. The medicine works by interfering with the parasite’s nervous system. It stops the signals that allow the parasite to move and live. This leads to the parasite’s death. The body then removes the parasite via the immune system.
Ivermectin has been used for a long time to treat parasitic infections. It has played a major role in controlling parasitic infections worldwide.
Why Researchers Study Ivermectin and Cancer
Sometimes, scientists examine existing medicines to determine whether they have other effects on the body. This is called drug repurposing. It gives scientists a chance to investigate and find whether they can use a particular medicine to treat another.
Scientists have studied how Ivermectin interacts with certain cells in the body. Some studies indicate that the drug may affect aspects of cell growth and survival. Since cancer involves uncontrolled cell growth, scientists have investigated whether Ivermectin could affect cancer cells. Such studies are often conducted in a lab, using cell culture or animal models. The results of the studies can give the researcher a better idea of how a compound can work with cells. However, the results of the studies do not necessarily mean that the drug can treat cancer.
Let us discuss the latest scientific evidence to determine whether there is a link between Ivermectin and cancer.
Current Scientific Evidence
Currently, Ivermectin is not approved for the treatment of cancer. Medical organizations and health authorities do not recommend this drug for the treatment of cancer. Most available studies are still in the early stages of research. Scientists still need to study the interaction between ivermectin and the body. Some studies show that Ivermectin’s effects on certain cellular processes can contribute to cancer. Some cellular processes include inflammation and the body’s response to diseases. Despite these studies, clinical trials involving human subjects are needed to demonstrate the benefits of a drug in the treatment and prevention of cancer. Without such trials, no one can prove that a drug can benefit a person in the fight against cancer. Patients undergoing cancer treatment should consult qualified medical professionals.
Importance of Evidence-Based Treatment
Cancer treatment involves medical assessment and evidence-based medicine. Doctors administer medicines that have been tested for safety and efficacy in clinical trials. This may include surgery, chemotherapy, radiation, immunotherapy, or targeted therapy. Unproven medicine may delay patients from seeking medical care, resulting in health hazards for those who need urgent care. This is why medical experts advise patients to seek proven medicine.
It is always important for patients with cancer to seek medical consultation on available treatment options with their medical care providers. Doctors may help patients understand the benefits and risks of different treatment options to ensure their safety and the efficacy of treatment.
Is Ivermectin an Approved Medicine to Treat Cancer?
Ivermectin is not approved or recommended for the treatment of cancer because there is a lack of good-quality human research evidence to support its use.
- Preclinical Results: Studies on ivermectin, which have shown promise against cancer, such as inhibiting tumor growth, have used doses much higher than the safe human dose.
- Research Status: Research on Ivermectin for cancer treatment is extremely limited, with only a small number of studies currently underway.
- Medical Consensus: According to health experts, Ivermectin should not be used for the treatment of cancer, as substituting its use for proven, evidence-based treatment can be harmful.
Although the drug can be repurposed, the research results are lacking. However, the use of the drug for the treatment of cancer should always be sought from a qualified medical professional.
Final Thoughts
The research on the effects of Ivermectin on cancer has just begun. Some studies on the effects of Ivermectin on cancer cells have been done. Further research is underway to demonstrate the drug’s effectiveness in treating human cancer. Patients must stick to the medication for cancer that their doctors prescribe.